This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Metabolix's CEO Presents At The Jefferies 2012 Global Industrial And A&D Conference (Transcript)

Stocks in this article: MBLX

The technology that we have over 700 patents in is in areas called PHAs, otherwise known as polyhydroxyalkanoates, and these are natural storage molecules, and I'd like to describe it. Just as the human body stores energy in the form of fat, plants and microbes store energy in the form of these PHAs, and what we have managed to do is to figure out how to produce these PHAs at commercially viable quantities and really have started to make great progress in a wide range of end-use applications for these PHAs.

We produce them in two ways. In the left-hand-side, you can see a fermentation and at the end of a fermentation cycle over 80% by way of a microbe these PHAs [by way]. On the right-hand-side, because these are naturally occurring materials, we could also produce them directly in the leaf tissue of crops which offers a game-changing approach for production of chemicals and plastics.

We manage the company all around these PHA capabilities in three platforms. From going from left to right, they are in order of timing towards commercialization.

First is a family of bioplastics, which we call Mirel and these are biopolymers which can be molded into parts flow into bags, turned into phones, and I'll get into the details in a few minutes, but it's been proving technical at commercial scale. Just recently, we announced the Letter of Intent to introduce manufacturing of these materials with a company called Antibioticos, and we are aiming for production in 2013, as we bring these materials to market.

The second platform is an industrial chemicals platform, and this is a bit different and that the materials we produce here are the same chemicals that you find the market today except they are produced by renewable sources instead of petroleum based, so these cases either is what they call drop in chemicals, and here we've got a series of families working in all based on the same competency for the Mirel family of materials and we've announced the relationship with the company called CJ BIO, a Korean industrial biotechnology company.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs